vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $53.8M, roughly 1.6× SMARTFINANCIAL INC.). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs 22.8%, a 2.6% gap on every dollar of revenue. Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 15.4%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
FDMT vs SMBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $53.8M |
| Net Profit | $19.4M | $13.7M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | — |
| Net Margin | 22.8% | 25.4% |
| Revenue YoY | 8508900.0% | — |
| Net Profit YoY | 139.1% | 21.6% |
| EPS (diluted) | $0.43 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $53.8M | ||
| Q4 25 | $85.1M | $53.3M | ||
| Q3 25 | $90.0K | $51.1M | ||
| Q2 25 | $15.0K | $49.2M | ||
| Q1 25 | $14.0K | $46.8M | ||
| Q4 24 | $1.0K | $46.8M | ||
| Q3 24 | $3.0K | $44.2M | ||
| Q2 24 | $5.0K | $40.4M |
| Q1 26 | — | $13.7M | ||
| Q4 25 | $19.4M | $13.7M | ||
| Q3 25 | $-56.9M | $13.7M | ||
| Q2 25 | $-54.7M | $11.7M | ||
| Q1 25 | $-48.0M | $11.3M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $-43.8M | $9.1M | ||
| Q2 24 | $-35.0M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 17.3% | 31.3% | ||
| Q3 25 | -67983.3% | 33.2% | ||
| Q2 25 | -396373.3% | 29.0% | ||
| Q1 25 | -383007.1% | 29.0% | ||
| Q4 24 | — | 26.5% | ||
| Q3 24 | -1704400.0% | 24.3% | ||
| Q2 24 | -849120.0% | 25.6% |
| Q1 26 | — | 25.4% | ||
| Q4 25 | 22.8% | 25.7% | ||
| Q3 25 | -63195.6% | 26.8% | ||
| Q2 25 | -364386.7% | 23.8% | ||
| Q1 25 | -342657.1% | 24.0% | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | -1461433.3% | 20.7% | ||
| Q2 24 | -699060.0% | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | $0.43 | $0.81 | ||
| Q3 25 | $-1.01 | $0.81 | ||
| Q2 25 | $-0.98 | $0.69 | ||
| Q1 25 | $-0.86 | $0.67 | ||
| Q4 24 | — | $0.57 | ||
| Q3 24 | $-0.79 | $0.54 | ||
| Q2 24 | $-0.63 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $346.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $562.2M |
| Total Assets | $566.7M | $5.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $346.1M | ||
| Q4 25 | $402.7M | $464.4M | ||
| Q3 25 | $305.1M | $557.1M | ||
| Q2 25 | $293.2M | $365.1M | ||
| Q1 25 | $321.4M | $423.0M | ||
| Q4 24 | $424.9M | $387.6M | ||
| Q3 24 | $501.9M | $192.9M | ||
| Q2 24 | $541.9M | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | $505.7M | $552.4M | ||
| Q3 25 | $369.0M | $538.4M | ||
| Q2 25 | $420.9M | $519.0M | ||
| Q1 25 | $469.7M | $505.8M | ||
| Q4 24 | $510.6M | $491.3M | ||
| Q3 24 | $552.9M | $489.0M | ||
| Q2 24 | $588.3M | $472.5M |
| Q1 26 | — | $5.9B | ||
| Q4 25 | $566.7M | $5.9B | ||
| Q3 25 | $424.0M | $5.8B | ||
| Q2 25 | $473.6M | $5.5B | ||
| Q1 25 | $515.7M | $5.4B | ||
| Q4 24 | $560.4M | $5.3B | ||
| Q3 24 | $604.0M | $4.9B | ||
| Q2 24 | $620.1M | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | — |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.6M | $61.7M | ||
| Q3 25 | $-46.5M | $16.9M | ||
| Q2 25 | $-43.4M | $14.0M | ||
| Q1 25 | $-47.8M | $14.3M | ||
| Q4 24 | $-134.6M | $52.7M | ||
| Q3 24 | $-29.4M | $12.4M | ||
| Q2 24 | $-30.2M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $28.5M | $59.3M | ||
| Q3 25 | $-46.6M | $16.6M | ||
| Q2 25 | $-43.4M | $13.2M | ||
| Q1 25 | $-48.4M | $13.4M | ||
| Q4 24 | $-138.4M | $46.3M | ||
| Q3 24 | $-31.2M | $11.3M | ||
| Q2 24 | $-30.6M | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | 33.5% | 111.3% | ||
| Q3 25 | -51765.6% | 32.4% | ||
| Q2 25 | -289620.0% | 26.9% | ||
| Q1 25 | -345635.7% | 28.5% | ||
| Q4 24 | -13837100.0% | 98.9% | ||
| Q3 24 | -1038966.7% | 25.7% | ||
| Q2 24 | -611840.0% | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 4.5% | ||
| Q3 25 | 101.1% | 0.6% | ||
| Q2 25 | 440.0% | 1.6% | ||
| Q1 25 | 4507.1% | 2.0% | ||
| Q4 24 | 378600.0% | 13.7% | ||
| Q3 24 | 59266.7% | 2.4% | ||
| Q2 24 | 6980.0% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.47× | 4.50× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | — | 5.47× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 2.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
